Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Dry eye of moderate severity with ocular rosacea diagnosed by ophthalmologist. No contraindications of severe ocular surface disease or inability to be safely treated with IPL.~Dry eye symptoms must be alleviated with topical anesthetic. No GVHD, Stevens Johnson, active allergic conjunctivitis or other conjunctivitis, alkali burn history.~Subjects must have at least 50% meibomian glands viable on meibography and no new treatments for dry eye in the past 6 months.~Contact lenses and refractive surgery is okay.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- MGX and Intense Pulsed Light Treatment (IPL) (Type: EXPERIMENTAL): Treatment with 4 visits and 4 treatments of IPL and Meibomian Gland Expression (MGX)
- Meibomian Gland Expression (MGX) (Type: ACTIVE_COMPARATOR): Treatment with 4 visits and 4 treatments of MGX only

Based on this trial design, predict the completion outcome and termination type (if applicable).